Physician profile
Carl Bruning
NPI 1366447328
$16,364.36
in general payments reported to CMS, 2019-2025
50 companies · $2,167 in 2025
The $2,167 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,932 · 2020: $1,526 · 2021: $2,048 · 2022: $2,694 · 2023: $3,116 · 2024: $2,882 · 2025: $2,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,164.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,867.22 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $1,861.21 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $1,736.05 | 2019-2024 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $1,080.91 | 2019-2025 | Provenge |
| Myovant Sciences INC. | $1,042.00 | 2021-2022 | |
| Boston Scientific Corporation | $894.50 | 2019-2025 | Ams 700, Solyx Sis System, Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $779.52 | 2019-2025 | |
| Pfizer INC. | $711.33 | 2019-2025 | |
| Coloplast Corp | $688.36 | 2019-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $564.62 | 2019-2024 | Xiaflex, Aveed, Edex |
| Astrazeneca Pharmaceuticals Lp | $495.28 | 2020-2025 | Lynparza |
| Myriad Genetic Laboratories, INC. | $399.48 | 2020-2024 | Prolaris, Precisetumor |
| Antares Pharma, INC. | $361.15 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $324.91 | 2024-2025 | Xiaflex, Aveed |
| Janssen Scientific Affairs, LLC | $279.47 | 2019-2025 | Erleada, Balversa, Akeega |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $271.78 | 2021-2024 | Trelstar |
| Abbvie INC. | $247.15 | 2019-2023 | Lupron Depot |
| Progenics Pharmaceuticals, INC. | $242.02 | 2022-2025 | Pylarify |
| Olympus America INC. | $227.67 | 2019-2025 | Itind System, Olympus |
| Merck Sharp & Dohme LLC | $226.64 | 2020-2025 | Keytruda, Lynparza |
| Urovant Sciences INC | $220.27 | 2021-2022 | |
| Axonics, INC. | $202.41 | 2020-2023 | Axonics |
| Ferring Pharmaceuticals INC. | $162.61 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $152.12 | 2019-2022 | |
| Tolmar, INC. | $139.92 | 2024-2025 | Jatenzo, Eligard |
| Novartis Pharmaceuticals Corporation | $119.42 | 2024-2025 | |
| Agiliti Surgical, INC. | $116.22 | 2023-2025 | Sonablate, Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Urogen Pharma, INC. | $96.32 | 2021-2025 | Jelmyto |
| Accord Healthcare, INC. | $90.76 | 2022-2023 | |
| Metuchen Pharmaceuticals | $90.12 | 2019-2020 | |
| Travere Therapeutics, INC. | $81.63 | 2020-2022 | |
| Dentsply Ih INC. | $66.99 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $47.03 | 2022 | |
| Azurity Pharmaceuticals, INC. | $46.56 | 2025 | Azmiro |
| Bioprotect Medical, INC. | $44.89 | 2025 | Bioprotect Balloon Implant System |
| Hollister Incorporated | $42.43 | 2022 | |
| Palette Life Sciences, INC. | $41.51 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $40.30 | 2022 | |
| Immunitybio, INC. | $38.64 | 2024-2025 | |
| Genzyme Corporation | $30.97 | 2023 | |
| Procept Biorobotics Corporation | $29.64 | 2023-2025 | Aquabeam Robotic System |
| Amgen INC. | $26.33 | 2019-2021 | |
| Abbott Laboratories | $23.43 | 2022 | |
| Ethicon US, LLC | $20.14 | 2019 | |
| Conmed Corporation | $18.62 | 2023 | Airseal |
| Ambu INC. | $17.83 | 2024 | |
| Medtronic, INC. | $15.92 | 2023 | Interstim |
| Acelrx Pharmaceuticals, INC. | $15.38 | 2020 | |
| Acerus Pharmaceuticals Corporation | $15.11 | 2021 | |
| Clovis Oncology, INC. | $9.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Bruning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.